Coronary Artery Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Coronary artery disease is the most common cause of death globally and is linked to a number of risk factors including serum low density lipoprotein, high density lipoprotein, triglycerides and lipoprotein(a).
|
29713054 |
2018 |
Coronary Artery Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Coronary heart disease risk correlates directly with plasma concentrations of lipoprotein(a) (Lp(a)), a low-density lipoprotein-like particle distinguished by the presence of the glycoprotein apolipoprotein(a) (apo(a)), which is bound to apolipoprotein B-100 (apoB-100) by disulfide bridges.
|
2976021 |
1988 |
Coronary Artery Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) is a plasma particle which is considered to be a risk factor for the development of coronary heart disease.
|
10095988 |
1999 |
Coronary Artery Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) [Lp(a)] has been considered to be a predictor of premature coronary heart disease and other cardiovascular diseases.
|
10098351 |
1999 |
Coronary Artery Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a)-apheresis in the secondary prevention of coronary heart disease.
|
10168548 |
1996 |
Coronary Artery Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein(a). A genetic risk factor for premature coronary heart disease.
|
1534588 |
1992 |
Coronary Artery Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.
|
15553596 |
2004 |
Coronary Artery Disease
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Lipoprotein (a) (Lp(a)) is a low density lipoprotein-like particle which contains the plasminogen-like apolipoprotein a. Lp(a) levels are elevated in patients with atherosclerotic coronary artery disease.
|
1824942 |
1991 |
Coronary Artery Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein(a): a causal independent risk factor for coronary heart disease?
|
19623058 |
2009 |
Coronary Artery Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein(a) [Lp(a)] is an established risk factor for coronary disease and stroke, but mechanisms underlying this association are unknown.
|
21078622 |
2011 |
Coronary Artery Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
lipoprotein(a) [Lp(a)] level is an established risk factor for coronary artery disease and has been implicated in carotid artery disease (CAAD).
|
21127300 |
2011 |
Coronary Artery Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) [Lp(a)] is a macromolecular complex found in human plasma that combines structural elements from the lipoprotein and blood clotting systems and that is associated with premature coronary heart disease and stroke.
|
2530631 |
1989 |
Coronary Artery Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) [Lp(a)] has recently been recognized as an independent risk factor for coronary heart disease.
|
25604958 |
2015 |
Coronary Artery Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) [Lp(a)] increases CAD in FH, although the independence of this association relative to other CAD risk factors remains unclear.
|
26340131 |
2015 |
Coronary Artery Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein (a) (Lp(a)), a well-established risk factor for coronary artery diseases (CAD), would also be anticipated to be associated in a similar manner with risk of type 2 diabetes mellitus (T2DM) based on the common soil hypothesis of etiology of T2DM and CAD.
|
28132096 |
2017 |
Coronary Artery Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) as a predictor of poor collateral circulation in patients with chronic stable coronary heart disease.
|
28700032 |
2017 |
Coronary Artery Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) is independently correlated with left ventricular systolic dysfunction in patients with hypertension and without CAD.
|
28883849 |
2017 |
Coronary Artery Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein(a) and the Apolipoprotein B/A1 Ratio Independently Associate With Surgery for Aortic Stenosis Only in Patients With Concomitant Coronary Artery Disease.
|
29246959 |
2017 |
Coronary Artery Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein(a) (Lp[a]) is proatherosclerotic and prothrombotic, causally related to coronary disease, and associated with other cardiovascular diseases.
|
29246963 |
2017 |
Coronary Artery Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein(a) (Lp(a)) is a causal risk factor for cardiovascular disorders including coronary heart disease and calcific aortic valve stenosis.
|
29852400 |
2018 |
Coronary Artery Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein(a) [Lp(a)] is an enigmatic lipoprotein which has been identified as a causal risk factor for coronary heart disease and calcific aortic valve disease.
|
29990619 |
2018 |
Coronary Artery Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein(a) [Lp(a)] has been classified as the most prevalent genetic risk factor for coronary artery disease and aortic valve stenosis.
|
30087087 |
2018 |
Coronary Artery Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease.
|
30447089 |
2019 |
Coronary Artery Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) and other ASCVD risk factors were measured at baseline (1996-1998) in the biracial Atherosclerosis Risk in Communities study; participants without prevalent ASCVD (coronary heart disease or stroke) were monitored ∼15 years for incident ASCVD events.
|
30685442 |
2019 |
Coronary Artery Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Prediabetes or Diabetes.
|
31076417 |
2019 |